Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitroglycerin Administration Routes for Coronary CT Angiography
NCT02961946Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nitroglycerin in coronary artery disease (CAD), sponsored by Massachusetts General Hospital. Started Mar 2017; status: completed.
02
Drugs
nitroglycerin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02961946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02961946.